Anastrozole Tablets 1mg

• Customization: Available
• Package: 2*14tablets/Box
• Composition: Anastrozole
• Model NO.: 1mg
• Specification: 1mg
• Trademark: Sinolead
• Origin: China

Product Description

Product	Dose	Package
Anastrozole Tablets	1mg	2*14Tablets/box

• Anastrozole Tablets is a nonsteroidal aromatase inhibitor that selectively inhibits the conversion of androgens to estrogens in peripheral tissues, such as adipose tissue and tumors. Anastrozole Tablets contain anastrozole as the active ingredient and are formulated for oral administration.

Indications:
 

Anastrozole Tablets are indicated for:

• Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer: Anastrozole is used as part of adjuvant therapy to reduce the risk of recurrence in postmenopausal women with hormone receptor-positive early breast cancer.
• Treatment of advanced breast cancer: It may also be used in the treatment of advanced or metastatic breast cancer in postmenopausal women who have progressed following tamoxifen therapy or as first-line therapy in hormone receptor-positive or hormone receptor unknown advanced breast cancer.

Administration:
 

Anastrozole Tablets are taken orally, usually once daily with or without food, as directed by a healthcare professional. The dosage and duration of treatment depend on the specific condition being treated, the patient's response to therapy, and any concomitant medications. Patients should swallow the tablets whole with a glass of water and should not crush or chew them.

Safety and Considerations:

While generally well-tolerated, Anastrozole Tablets may cause side effects such as:

• Musculoskeletal symptoms: Joint pain, stiffness, or arthritis-like symptoms are common side effects of anastrozole therapy.
• Osteoporosis: Long-term use of anastrozole may increase the risk of osteoporosis-related fractures due to estrogen suppression. Bone mineral density should be monitored regularly, and appropriate preventive measures should be taken.
• Cardiovascular events: Anastrozole may increase the risk of cardiovascular events such as myocardial infarction or stroke, particularly in patients with pre-existing cardiovascular disease or risk factors.